Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermaQuip is a private healthcare technology and aesthetics-device company focused on professional skin analysis and facial imaging systems for dermatology, med spa, plastic surgery, and skincare practices. Founded in 2014, the company markets its PEAR imaging platform, including PEAR 3D Plus and related systems, which provide high-resolution facial imaging and skin analysis for pores, wrinkles, pigmentation, texture, oil, bacteria, and sun damage. DermaQuip appears to operate as a commercial-stage device business rather than a drug-development biotech company, with revenue generated from equipment sales and financing-supported placements. Its business is centered on workflow enhancement, patient consultation, treatment tracking, and practice conversion support for aesthetic providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermaQuip.